About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 508623, 8 pages
http://dx.doi.org/10.1155/2012/508623
Research Article

Depression, Comorbidities, and Prescriptions of Antidepressants in a German Network of GPs and Specialists with Subspecialisation in Anthroposophic Medicine: A Longitudinal Observational Study

1Havelhoehe Research Institute, Kladower Damm 221, 14089 Berlin, Germany
2Center for Integrative Medicine, University of Witten/Herdecke, Gerhard-Kienle-Weg 4, 58313 Herdecke, Germany
3Department of General Practice, University of Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany
4Institute for General Practice and Family Medicine, University of Witten/Herdecke, Alfred-Herrhausen-Straße 50, 58448 Witten, Germany

Received 12 July 2012; Accepted 8 October 2012

Academic Editor: Jörg Melzer

Copyright © 2012 Elke Jeschke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Moussavi, S. Chatterji, E. Verdes, A. Tandon, V. Patel, and B. Ustun, “Depression, chronic diseases, and decrements in health: results from the World Health Surveys,” The Lancet, vol. 370, no. 9590, pp. 851–858, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. World Health Organisation, “Mental health, new understanding, new hope,” World Health Report 2001, WHO, Geneva, Switzerland, 2001, http://www.who.int/whr/2001/en/whr01_en.pdf.
  3. A. Bramesfeld, T. Grobe, and F. W. Schwartz, “Prevalence of depression diagnosis and prescription of antidepressants in East and West Germany: an analysis of health insurance data,” Social Psychiatry and Psychiatric Epidemiology, vol. 45, no. 3, pp. 329–335, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Ornstein, G. Stuart, and R. Jenkins, “Depression diagnoses and antidepressant use in primary care practices: a study from the practice partner research network (PPRNet),” Journal of Family Practice, vol. 49, no. 1, pp. 68–72, 2000. View at Scopus
  5. A. Bramesfeld, T. G. Grobe, and F. W. Schwartz, “Who is diagnosed as suffering from depression in the German statutory health care system? An analysis of health insurance data,” European Journal of Epidemiology, vol. 22, no. 6, pp. 397–403, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. “für die Leitliniengruppe Unipolare Depression,” in S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression-Langfassung, DGPPN, BÄK, KBV et al., Eds., DGPPN, ÄZQ, AWMF, Berlin, Germany, 1st edition, 2009, http://www.dgppn.de/http://www.versorgungsleitlinien.de/http://awmf-leitlinien.de/.
  7. H. U. Wittchen, M. Höfler, and W. Meister, “Prevalence and recognition of depressive syndromes in german primary care settings: poorly recognized and treated?” International Clinical Psychopharmacology, vol. 16, no. 3, pp. 121–135, 2001. View at Scopus
  8. M. Härter, I. Bermejo, G. Ollenschläger et al., “Improving quality of care for depression: The German Action Programme for the implementation of evidence-based guidelines,” International Journal for Quality in Health Care, vol. 18, no. 2, pp. 113–119, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Härter, C. Klesse, I. Bermejo et al., “Evidence-based therapy of depression. S3 guidelines on unipolar depression,” Nervenarzt, vol. 81, no. 9, pp. 1049–1068, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Holsboer-Trachsler, J. Hättenschwiler, J. Beck et al., “Die somatische Behandlung der unipolaren depressiven Störungen,” Schweiz Med Forum, vol. 10, pp. 802–809, 2010.
  11. A. V. Ravindran, R. W. Lam, M. J. Filteau et al., “Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments,” Journal of Affective Disorders, vol. 117, no. 1, pp. S54–S64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Kasper, F. Caraci, B. Forti, F. Drago, and E. Aguglia, “Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression,” European Neuropsychopharmacology, vol. 20, no. 11, pp. 747–765, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Linde, M. M. Berner, and L. Kriston, “St John's wort for major depression,” Cochrane Database of Systematic Reviews, no. 4, article CD000448, 2008. View at Scopus
  14. A. V. Dwyer, D. L. Whitten, and J. A. Hawrelak, “Herbal medicines, other than St. John's Wort, in the treatment of depression: a systematic review,” Alternative Medicine Review, vol. 16, no. 1, pp. 40–49, 2011. View at Scopus
  15. J. R. T. Davidson, C. Crawford, J. A. Ives, and W. B. Jonas, “Homeopathic treatments in psychiatry: a systematic review of randomized placebo-controlled studies,” Journal of Clinical Psychiatry, vol. 72, no. 6, pp. 795–805, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Jeschke, T. Ostermann, M. Tabali et al., “Diagnostic profiles and prescribing patterns in everyday anthroposophic medical practice—a prospective multi-centre study,” Forschende Komplementarmedizin, vol. 16, no. 5, pp. 325–333, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Tabali, E. Jeschke, C. M. Witt, T. Ostermann, and H. Matthes, “Adverse drug reactions for CAM and Conventional drugs detected in a network of Physicians Certified to prescribe CAM drugs,” Journal of Managed Care Pharmacy, vol. 18, no. 6, pp. 427–438, 2012.
  18. Arbeitsgruppe Erhebung und Nutzung von Sekundärdaten der Deutschen Gesellschaft für Sozialmedizin und Prävention, Arbeitsgruppe Epidemiologische Methoden der Deutschen Gesellschaft für Epidemiologie, Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie, and Deutschen Gesellschaft für Sozialmedizin und Prävention, “Good practice of secondary data analysis, first revision,” Gesundheitswesen, vol. 701, pp. 54–60, 2008.
  19. E. Jeschke, F. Schad, J. Pissarek, B. Matthes, U. Albrecht, and H. Matthes, “QuaDoSta—ein frei konfigurierbares System zur Unterstützung multizentrischer Datenerhebungen in medizinischer Versorgung und Forschung,” GMS Medizinische Informatik, Biometrie Und Epidemiologie, vol. 3, no. 10, 2007.
  20. Kassenärztliche Bundesvereinigung (KBV), “Grunddaten zur Vertragsärztlichen Versorgung in Deutschland 2011,” http://www.kbv.de/publikationen/125.html.
  21. J. M. Gill, X. C. Ying, and M. I. Lieberman, “Management of depression in ambulatory care for patients with medical co-morbidities: a study from a national electronic health record (EHR) network,” International Journal of Psychiatry in Medicine, vol. 38, no. 2, pp. 203–215, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. J. M. Gill, M. S. Klinkman, and Y. X. Chen, “Antidepressant medication use for primary care patients with and without medical comorbidities: a national Electronic Health Record (EHR) network study,” Journal of the American Board of Family Medicine, vol. 23, no. 4, pp. 499–508, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. W. D. Robinson, J. A. Geske, L. A. Prest, and R. Barnacle, “Depression treatment in primary care,” Journal of the American Board of Family Practice, vol. 18, no. 2, pp. 79–86, 2005. View at Scopus
  24. M. Sieberer, “Auswertungsergebnisse der BARMER GEK Arzneimitteldaten aus den Jahren 2008 und 2009,” in BARMER GEK Arzneimittel-Report 2010, G. Glaeske and C. Schicktanz, Eds., vol. 2, pp. 137–149, Schriftenreihe zur Gesundheitsanalyse, 2010.
  25. T. Grobe and H. Dörning, Gesundheits report 2010—Veröffentlichungen zum Betrieblichen Gesundheitsmanagement der TK, vol. 24, Techniker Krankenkasse, Hamburg, Germany, http://www.tk-online.de/.
  26. J. Moncrieff and D. Cohen, “Do antidepressants cure or create abnormal brain states?” PLoS Medicine, vol. 3, no. 7, article e240, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Kirsch, B. J. Deacon, T. B. Huedo-Medina, A. Scoboria, T. J. Moore, and B. T. Johnson, “Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration,” PLoS Medicine, vol. 5, no. 2, article e45, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Katon and M. D. Sullivan, “Depression and chronic medical illness,” Journal of Clinical Psychiatry, vol. 51, 1, pp. 3–11, 1990. View at Scopus
  29. F. Jacobi, H. U. Wittchen, C. Hölting et al., “Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS),” Psychological Medicine, vol. 34, no. 4, pp. 597–611, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. World Health Organization (WHO), Wellbeing Measures in Primary Health Care: The DepCare Project, WHO, Copenhagen, Denmark, 1998.
  31. R. L. Spitzer, K. Kroenke, and J. B. W. Williams, “Validation and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study,” Journal of the American Medical Association, vol. 282, no. 18, pp. 1737–1744, 1999. View at Publisher · View at Google Scholar · View at Scopus